BGNE - BeiGene's Brukinsa gets Europe approval for follicular lymphoma
2023-11-17 07:35:11 ET
More on BeiGene
- BeiGene: Staying On The Sidelines (Rating Downgrade)
- BeiGene regains full rights to cancer therapy from Novartis
- Seeking Alpha’s Quant Rating on BeiGene
- Historical earnings data for BeiGene
- Financial information for BeiGene
For further details see:
BeiGene's Brukinsa gets Europe approval for follicular lymphoma